Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 7,000 | 0 |
| Gross Profit | N/A | N/A | N/A | 7,000 | N/A |
| Operating Expenses | 23,383 | 23,711 | 34,589 | 32,527 | 26,784 |
| Operating Income | -23,383 | -23,711 | -34,589 | -25,527 | -26,784 |
| Interest Expense | 401 | 400 | 399 | 396 | 385 |
| Other Income | 2,237 | 2,453 | 2,728 | 2,820 | 2,861 |
| Pre-tax Income | -21,547 | -21,658 | -32,260 | -23,103 | -24,308 |
| Net Income Continuous | -21,547 | -21,658 | -32,260 | -23,103 | -24,308 |
| Net Income | $-21,547 | $-21,658 | $-32,260 | $-23,103 | $-24,308 |
| EPS Basic Total Ops | -2.96 | -2.98 | -4.36 | -3.18 | -3.40 |
| EPS Basic Continuous Ops | -2.96 | -2.98 | -4.44 | -3.18 | -3.35 |
| EPS Diluted Total Ops | -2.96 | -2.98 | -4.36 | -3.18 | -3.40 |
| EPS Diluted Continuous Ops | -2.96 | -2.98 | -4.44 | -3.18 | -3.35 |
| EPS Diluted Before Non-Recurring Items | -2.80 | -3.00 | -3.50 | N/A | N/A |
| EBITDA(a) | $-24,446 | $-24,900 | $-35,782 | $-26,957 | $-28,295 |